National Quality Forum (NQF) Releases Anticoagulation Stewardship Playbook to Help Improve Patient Safety - Drug Information Update

This new guide offers proven strategies to reduce preventable adverse drug events.

CENTER FOR DRUG EVALUATION AND RESEARCH DIVISION of DRUG INFORMATION Your source for the latest drug information. Know the moment it happens. National Quality Forum (NQF) Releases Anticoagulation Stewardship Playbook to Help Improve Patient Safety More than 8 million people in the U.S. take anticoagulants, which work by decreasing the blood's ability to clot. They are essential and life-saving for people with cardiac and vascular disorders, but have been identified as the most common cause of adverse drug events (ADEs) across various healthcare settings. The National Quality Forum (NQF), in partnership with the Anticoagulation Forum (AC Forum) and with funding from the U.S. Food and Drug Administration (FDA), has released Advancing Anticoagulation Stewardship: A Playbook, a new, publicly available guide to help healthcare organizations implement evidence-based strategies to promote patient safety in the use of anticoagulant medications. This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA